vs

Side-by-side financial comparison of Everest Group (EG) and Zimmer Biomet (ZBH). Click either name above to swap in a different company.

Everest Group is the larger business by last-quarter revenue ($4.1B vs $2.1B, roughly 1.9× Zimmer Biomet). Everest Group runs the higher net margin — 16.1% vs 11.4%, a 4.6% gap on every dollar of revenue. On growth, Zimmer Biomet posted the faster year-over-year revenue change (9.3% vs -4.6%). Over the past eight quarters, Zimmer Biomet's revenue compounded faster (3.7% CAGR vs -1.9%).

Everest Group is a leading global reinsurance and insurance provider operating across over 100 countries. It offers diversified property, casualty, specialty, and life insurance products for commercial enterprises and individual customers, with strong risk management capabilities and long-standing industry expertise.

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.

EG vs ZBH — Head-to-Head

Bigger by revenue
EG
EG
1.9× larger
EG
$4.1B
$2.1B
ZBH
Growing faster (revenue YoY)
ZBH
ZBH
+13.9% gap
ZBH
9.3%
-4.6%
EG
Higher net margin
EG
EG
4.6% more per $
EG
16.1%
11.4%
ZBH
Faster 2-yr revenue CAGR
ZBH
ZBH
Annualised
ZBH
3.7%
-1.9%
EG

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
EG
EG
ZBH
ZBH
Revenue
$4.1B
$2.1B
Net Profit
$653.0M
$238.3M
Gross Margin
64.6%
Operating Margin
17.9%
Net Margin
16.1%
11.4%
Revenue YoY
-4.6%
9.3%
Net Profit YoY
211.0%
30.5%
EPS (diluted)
$1.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EG
EG
ZBH
ZBH
Q1 26
$4.1B
$2.1B
Q4 25
$4.4B
$2.2B
Q3 25
$4.3B
$2.0B
Q2 25
$4.5B
$2.1B
Q1 25
$4.3B
$1.9B
Q4 24
$4.6B
$2.0B
Q3 24
$4.3B
$1.8B
Q2 24
$4.2B
$1.9B
Net Profit
EG
EG
ZBH
ZBH
Q1 26
$653.0M
$238.3M
Q4 25
$446.0M
$139.4M
Q3 25
$255.0M
$230.9M
Q2 25
$680.0M
$152.8M
Q1 25
$210.0M
$182.0M
Q4 24
$-593.0M
$239.5M
Q3 24
$509.0M
$249.1M
Q2 24
$724.0M
$242.8M
Gross Margin
EG
EG
ZBH
ZBH
Q1 26
64.6%
Q4 25
64.7%
Q3 25
72.1%
Q2 25
71.5%
Q1 25
71.2%
Q4 24
71.0%
Q3 24
70.5%
Q2 24
71.5%
Operating Margin
EG
EG
ZBH
ZBH
Q1 26
17.9%
Q4 25
12.5%
6.9%
Q3 25
6.2%
17.6%
Q2 25
18.1%
14.4%
Q1 25
5.8%
15.3%
Q4 24
-16.1%
19.2%
Q3 24
13.5%
15.3%
Q2 24
19.7%
18.1%
Net Margin
EG
EG
ZBH
ZBH
Q1 26
16.1%
11.4%
Q4 25
10.1%
6.2%
Q3 25
5.9%
11.5%
Q2 25
15.1%
7.4%
Q1 25
4.9%
9.5%
Q4 24
-12.8%
11.8%
Q3 24
11.9%
13.7%
Q2 24
17.1%
12.5%
EPS (diluted)
EG
EG
ZBH
ZBH
Q1 26
$1.22
Q4 25
$10.71
$0.71
Q3 25
$6.09
$1.16
Q2 25
$16.10
$0.77
Q1 25
$4.90
$0.91
Q4 24
$-13.59
$1.18
Q3 24
$11.80
$1.23
Q2 24
$16.70
$1.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EG
EG
ZBH
ZBH
Cash + ST InvestmentsLiquidity on hand
$2.2B
$424.2M
Total DebtLower is stronger
$7.5B
Stockholders' EquityBook value
$15.3B
$12.7B
Total Assets
$62.3B
$22.7B
Debt / EquityLower = less leverage
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EG
EG
ZBH
ZBH
Q1 26
$2.2B
$424.2M
Q4 25
$591.9M
Q3 25
$1.3B
Q2 25
$556.9M
Q1 25
$1.4B
Q4 24
$662.0M
$525.5M
Q3 24
$569.0M
Q2 24
$420.1M
Total Debt
EG
EG
ZBH
ZBH
Q1 26
$7.5B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
EG
EG
ZBH
ZBH
Q1 26
$15.3B
$12.7B
Q4 25
$15.5B
$12.7B
Q3 25
$15.4B
$12.8B
Q2 25
$15.0B
$12.5B
Q1 25
$14.1B
$12.4B
Q4 24
$13.9B
$12.5B
Q3 24
$15.3B
$12.4B
Q2 24
$14.2B
$12.7B
Total Assets
EG
EG
ZBH
ZBH
Q1 26
$62.3B
$22.7B
Q4 25
$62.5B
$23.1B
Q3 25
$62.2B
$23.5B
Q2 25
$60.5B
$22.9B
Q1 25
$58.1B
$22.2B
Q4 24
$56.3B
$21.4B
Q3 24
$55.9B
$21.7B
Q2 24
$52.6B
$21.5B
Debt / Equity
EG
EG
ZBH
ZBH
Q1 26
0.59×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EG
EG
ZBH
ZBH
Operating Cash FlowLast quarter
$359.4M
Free Cash FlowOCF − Capex
$245.9M
FCF MarginFCF / Revenue
11.8%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.51×
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EG
EG
ZBH
ZBH
Q1 26
$359.4M
Q4 25
$-398.0M
$517.4M
Q3 25
$1.5B
$418.7M
Q2 25
$1.1B
$378.2M
Q1 25
$928.0M
$382.8M
Q4 24
$780.0M
$506.3M
Q3 24
$1.7B
$395.7M
Q2 24
$1.3B
$369.4M
Free Cash Flow
EG
EG
ZBH
ZBH
Q1 26
$245.9M
Q4 25
$442.6M
Q3 25
$363.7M
Q2 25
$328.1M
Q1 25
$338.2M
Q4 24
$454.8M
Q3 24
$351.2M
Q2 24
$316.7M
FCF Margin
EG
EG
ZBH
ZBH
Q1 26
11.8%
Q4 25
19.7%
Q3 25
18.2%
Q2 25
15.8%
Q1 25
17.7%
Q4 24
22.5%
Q3 24
19.3%
Q2 24
16.3%
Capex Intensity
EG
EG
ZBH
ZBH
Q1 26
Q4 25
3.3%
Q3 25
2.7%
Q2 25
2.4%
Q1 25
2.3%
Q4 24
2.5%
Q3 24
2.4%
Q2 24
2.7%
Cash Conversion
EG
EG
ZBH
ZBH
Q1 26
1.51×
Q4 25
-0.89×
3.71×
Q3 25
5.72×
1.81×
Q2 25
1.59×
2.48×
Q1 25
4.42×
2.10×
Q4 24
2.11×
Q3 24
3.41×
1.59×
Q2 24
1.85×
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EG
EG

Premiums earned$3.6B88%
Other$494.0M12%

ZBH
ZBH

Segment breakdown not available.

Related Comparisons